Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MAT2A | P31153 | 7/20 | 0.32 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.31 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12456494 | 0.96 | KDM4E (0.46) | KDM4EATML3MBTL1MAT2AMAPK8 | |
| SCHEMBL12456723 | 0.94 | KDM4E (0.49) | KDM4EATML3MBTL1MAT2AMAPK8 | |
| SCHEMBL10061791 | 0.92 | L3MBTL1 (0.53) | KDM4EATML3MBTL1MAT2AMAPK8 | |
| SCHEMBL10061607 | 0.92 | L3MBTL1 (0.49) | KDM4EATML3MBTL1MAPK8MAPK9 | |
| SCHEMBL16999742 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1MAT2AMAPK8 | |
| SCHEMBL10205981 | 0.91 | L3MBTL1 (0.50) | KDM4EATML3MBTL1MAPK8MAPK9 | |
| SCHEMBL12456487 | 0.90 | KDM4E (0.50) | KDM4EATML3MBTL1MAT2AMAPK8 | |
| SCHEMBL14212993 | 0.89 | L3MBTL1 (0.41) | KDM4EATML3MBTL1MAT2AMAPK8 | |
| SCHEMBL10061790 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1MAT2AMAPK8 | |
| SCHEMBL10206003 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1MAT2AMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11271166-B2 | Light emitting device and composition useful for production of same light emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-03-08 | — | — | US | disclosed |
| US-20200216480-A1 | LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-07-09 | — | — | US | disclosed |
| US-20200152882-A1 | LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-14 | — | — | US | disclosed |
| US-20190259952-A1 | LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-08-22 | — | — | US | disclosed |
| US-20190221744-A1 | LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-18 | — | — | US | disclosed |
| US-20190214569-A1 | LIGHT EMITTING DEVICE AND COMPOSITION USEFUL FOR PRODUCTION OF SAME LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200216480-A1 | LIGHT EMITTING DEVICE | CRY1, CRY2, H1-2 | KDM4E 3611/4885ATM 1865/4885L3MBTL1 365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.